Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial (Q28364287)

Crossref

DOI

https://api.crossref.org/works/10.1136/BMJ.3.5724.676

19 March 2023

1 reference

https://api.crossref.org/works/10.1136/BMJ.3.5724.676

19 March 2023

author name string

N. Oker-Blom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

19 March 2023

T. Hovi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

19 March 2023

P. Leinikki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

19 March 2023

T. Palosuo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

19 March 2023

R. Pettersson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

19 March 2023

J. Suni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

full work available at URL

19 March 2023

language of work or name

English

0 references

publication date

19 September 1970

0 references

https://europepmc.org/articles/PMC1701794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

https://europepmc.org/articles/PMC1701794?pdf=render

19 March 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4919024

https://syndication.highwire.org/content/doi/10.1136/bmj.3.5724.676

19 March 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1136/BMJ.3.5724.676

19 March 2023

0 references

3

0 references

issue

5724

0 references

page(s)

676-8

0 references

cites work

Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Studies on the antiviral activity of 1-adamantanamine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Trial of amantadine in epidemic influenza

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Effect of 1-adamantanamine hydrochloride on Rous sarcoma virus in vitro and in vivo

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Studies on the antiviral activity of amantadine hydrochloride.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

RUBELLA VIRUS: INHIBITION IN VITRO BY AMANTADINE HYDROCHLORIDE.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

Influenza virus growth and antibody response in amantadine-treated mice

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1701794

A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness

27 November 2018

1 reference

12 December 2020

1-Adamantanamine hydrochloride: inhibition of Rous and Esh Sarcoma viruses in cell culture

1 reference

12 December 2020

Antiviral substances: 6-aminonicotinamide and 1-adamantanamine hydrochloride

1 reference

12 December 2020

The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride

1 reference

12 December 2020

[On the preventive effect of amantadine hydrochloride in influenza and other respiratory viral infections]

1 reference

12 December 2020

Identifiers

DOI

0 references

PMC publication ID

1701794

0 references